Background Angiotensin-converting enzyme (ACE) inhibitor use is presumed to be
contraindicated in patients with aortic stenosis (AS). We determined the hemodynamic …

Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

Objectives: Identify the mechanism of action of ACE inhibitors. Summarize monitoring/follow-
up for patients initiated on ACE inhibitor therapy. Review the dosing parameters adjusting or …

The chemistry, pharmacology, pharmacokinetics, adverse effects, and dosages of the three
currently available angiotensin-converting enzyme (ACE) inhibitors are reviewed. This class …

Objective To evaluate the effect of angiotensin receptor blockers on the risk of myocardial
infarction in patients at risk for cardiovascular events. Design Systematic review of controlled …

Background—Patients with reduced renal function are at increased risk for adverse
cardiovascular outcomes. In the post–myocardial infarction setting, angiotensin-converting …

The development of angiotensin-converting enzyme inhibitors (ACE inhibitors) has been
one of the most remarkable stories in the treatment of cardiovascular diseases. Angiotensin …

Objective To study the association of race and other patient characteristics associated with
angiotensin converting enzyme (ACE) inhibitor‐associated angioedema. Methods This was …

BACKGROUND: A modest (41%) reduction in abdominal aortic aneurysm (AAA) growth rate
is likely to delay AAA-related events (surgery or rupture) by 5 years, making the notion of …

Over 100 years of scientific investigation has established that angiotensin-converting
enzyme (ACE) plays an important role in both the renin–angiotensin system and the kinin …